SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||
For the quarterly period ended June 29, 2002 | ||
or | ||
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 0-27892
SIPEX Corporation
(Exact Name of Registrant as Specified in its Charter)
Massachusetts | 04-6135748 | |
(State or Other Jurisdiction of | (I.R.S. Employer | |
Incorporation or Organization) | Identification No.) | |
22 Linnell Circle, Billerica, Massachusetts | 01821 | |
(Address of principal executive offices) | (Zip Code) |
(978) 667-8700
Registrants telephone number, including area code
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
There were 27,955,682 shares of the Registrants Common Stock issued and outstanding as of August 2, 2002.
FORM 10-Q
THREE MONTHS ENDED JUNE 29, 2002
INDEX
Item | ||||||||
Number | Page | |||||||
PART I: | FINANCIAL INFORMATION |
|||||||
Item 1. | Financial Statements |
|||||||
Condensed Consolidated Balance Sheets at June 29, 2002 and December 31, 2001 |
3 | |||||||
Condensed Consolidated Statements of Operations for the three and six month periods
ended June 29, 2002 and June 30, 2001 |
4 | |||||||
Condensed Consolidated Statements of Cash Flows for the six month periods ended June
29, 2002 and June 30, 2001 |
5 | |||||||
Notes To Condensed Consolidated Financial Statements |
6-8 | |||||||
Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
9-20 | ||||||
Item 3. | Quantitative and Qualitative Disclosure about Market Risk |
20 | ||||||
PART II: | OTHER INFORMATION |
|||||||
Item 1. | Legal Proceedings |
21 | ||||||
Item 2. | Changes in Securities and Use of Proceeds |
21 | ||||||
Item 3. | Defaults Upon Senior Securities |
* | ||||||
Item 4. | Submission of Matters to a Vote of Security Holders |
21 | ||||||
Item 5. | Other Information |
* | ||||||
Item 6. | Exhibits and Reports on Form 8-K |
21 | ||||||
SIGNATURES |
22 |
* No information provided due to inapplicability of item.
2
Part I: FINANCIAL INFORMATION
Item 1: Financial Statements
SIPEX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
June 29, | December 31, | ||||||||||
2002 | 2001 | ||||||||||
(Unaudited) | (Audited) | ||||||||||
ASSETS: |
|||||||||||
Current Assets: |
|||||||||||
Cash and cash equivalents |
$ | 5,426 | $ | 4,874 | |||||||
Short-term investment securities |
5,961 | | |||||||||
Accounts receivable, less allowances of $982 and $2,444 at
June 29, 2002 and December 31, 2001, respectively |
11,952 | 10,966 | |||||||||
Inventories |
25,691 | 25,295 | |||||||||
Deferred income taxes-current |
| 3,163 | |||||||||
Prepaid expenses and other current assets |
1,902 | 1,871 | |||||||||
Total current assets |
50,932 | 46,169 | |||||||||
Property, plant, and equipment, net |
65,823 | 67,172 | |||||||||
Goodwill |
| 2,984 | |||||||||
Deferred income taxes |
| 28,688 | |||||||||
Other assets |
114 | 114 | |||||||||
Total assets |
$ | 116,869 | $ | 145,127 | |||||||
LIABILITIES AND SHAREHOLDERS EQUITY: |
|||||||||||
Current Liabilities: |
|||||||||||
Accounts payable |
$ | 10,378 | $ | 5,989 | |||||||
Accrued expenses |
4,130 | 2,928 | |||||||||
Deferred income |
819 | 992 | |||||||||
Total current liabilities |
15,327 | 9,909 | |||||||||
Long-term debt |
| 7,396 | |||||||||
Total liabilities |
15,327 | 17,305 | |||||||||
Shareholders equity: |
|||||||||||
Preferred stock, $.01 par value, 1,000 shares authorized
and no shares issued or outstanding at June 29, 2002
and December 31, 2001, respectively |
| | |||||||||
Common stock, $.01 par value, 40,000 shares authorized and
27,954 and 24,844 shares issued and outstanding at
June 29, 2002 and December 31, 2001, respectively |
279 | 248 | |||||||||
Additional paid-in capital |
173,642 | 149,447 | |||||||||
Accumulated deficit |
(72,353 | ) | (21,903 | ) | |||||||
Accumulated other comprehensive income (loss) |
(26 | ) | 30 | ||||||||
Total shareholders equity |
101,542 | 127,822 | |||||||||
Total liabilities and shareholders equity |
$ | 116,869 | $ | 145,127 | |||||||
See accompanying notes to condensed consolidated financial statements
3
SIPEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||||
June 29, | June 30, | June 29, | June 30, | |||||||||||||||
2002 | 2001 | 2002 | 2001 | |||||||||||||||
Net sales |
$ | 16,988 | $ | 19,372 | $ | 33,052 | $ | 39,066 | ||||||||||
Cost of sales |
18,931 | 21,671 | 32,820 | 40,468 | ||||||||||||||
Gross profit (loss) |
(1,943 | ) | (2,299 | ) | 232 | (1,402 | ) | |||||||||||
Operating expenses |
||||||||||||||||||
Research and development |
3,560 | 3,514 | 6,274 | 7,559 | ||||||||||||||
Marketing and selling |
2,206 | 2,628 | 4,472 | 5,287 | ||||||||||||||
General and administrative |
2,645 | 1,914 | 4,300 | 3,993 | ||||||||||||||
Restructuring and facility exit costs |
| 494 | | 177 | ||||||||||||||
Amortization/impairment of goodwill |
2,984 | 94 | 2,984 | 188 | ||||||||||||||
Total operating expenses |
11,395 | 8,644 | 18,030 | 17,204 | ||||||||||||||
(Loss) from operations |
(13,388 | ) | (10,943 | ) | (17,798 | ) | (18,606 | ) | ||||||||||
Other income (expense), net |
(329 | ) | (112 | ) | (716 | ) | 28 | |||||||||||
(Loss) before income taxes |
(13,667 | ) | (11,055 | ) | (18,514 | ) | (18,578 | ) | ||||||||||
Income tax expense (benefit) |
33,826 | (4,750 | ) | 31,936 | (7,245 | ) | ||||||||||||
Net (loss) |
$ | (47,493 | ) | $ | (6,305 | ) | $ | (50,450 | ) | $ | (11,333 | ) | ||||||
Net (loss) per common share-basic and assuming dilution |
$ | (1.70 | ) | $ | (0.26 | ) | $ | (1.91 | ) | $ | (0.49 | ) | ||||||
Weighted average common and common equivalent shares
outstanding-basic and assuming dilution |
27,930 | 23,983 | 26,402 | 23,248 | ||||||||||||||
See accompanying notes to condensed consolidated financial statements
4
SIPEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Six Months Ended | ||||||||||||
June 29, | June 30, | |||||||||||
2002 | 2001 | |||||||||||
Operating activities: |
||||||||||||
Net (loss) |
$ | (50,450 | ) | $ | (11,333 | ) | ||||||
Adjustments to reconcile net (loss) to net cash used in operating activities: |
||||||||||||
(Increase) decrease in deferred income taxes |
31,851 | (7,248 | ) | |||||||||
Provision for uncollectable receivables and returns and allowances |
713 | 1,803 | ||||||||||
Depreciation and amortization |
7,203 | 3,795 | ||||||||||
Change in other long-term liabilities |
| (1,396 | ) | |||||||||
Changes in current assets and liabilities: |
||||||||||||
(Increase) decrease in accounts receivable |
(1,699 | ) | 3,079 | |||||||||
Increase in inventories |
(396 | ) | (575 | ) | ||||||||
Increase in prepaid expenses and other assets |
(31 | ) | (703 | ) | ||||||||
Increase (decrease) in accounts payable |
4,389 | (2,660 | ) | |||||||||
Increase (decrease) in accrued expenses |
1,202 | (302 | ) | |||||||||
(Decrease) increase in deferred income |
(173 | ) | 310 | |||||||||
Net cash used in operating activities |
(7,391 | ) | (15,230 | ) | ||||||||
Investing activities: |
||||||||||||
Proceeds from restricted cash |
| 36,750 | ||||||||||
Purchase of investments |
(5,961 | ) | | |||||||||
Purchase of property, plant and equipment |
(2,870 | ) | (38,232 | ) | ||||||||
Net cash used in investing activities |
(8,831 | ) | (1,482 | ) | ||||||||
Financing activities: |
||||||||||||
Proceeds from issuance of common stock |
24,226 | 22,112 | ||||||||||
(Payments of) proceeds from debt obligations |
(7,396 | ) | 136 | |||||||||
Net cash provided by financing activities |
16,830 | 22,248 | ||||||||||
Effect of foreign currency translation adjustments |
(56 | ) | (53 | ) | ||||||||
Increase in cash and cash equivalents |
552 | 5,483 | ||||||||||
Cash and cash equivalents, beginning of period |
4,874 | 1,732 | ||||||||||
Cash and cash equivalents, end of period |
$ | 5,426 | $ | 7,215 | ||||||||
Supplemental cash flow information: |
||||||||||||
Cash paid during the period for: |
||||||||||||
Income taxes |
$ | 81 | $ | | ||||||||
Interest |
$ | 12 | $ | 360 |
See accompanying notes to condensed consolidated financial statements
5
SIPEX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Basis of Presentation
The consolidated financial statements include the accounts of Sipex Corporation (the Company) and all of its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.
The accompanying unaudited financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the financial statements and notes thereto for the year ended December 31, 2001, included in the Companys Form 10-K filing. The accompanying financial statements reflect all adjustments (consisting solely of normal, recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of results for the interim periods presented and were prepared based upon the accounting policies disclosed in the Companys Form 10-K. The results of operations for the three and six month periods ended June 29, 2002 are not necessarily indicative of the results to be expected for the full fiscal year.
2. Significant Accounting Policies
Recent Accounting Pronouncements
The FASB issued SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections, effective for fiscal years beginning May 15, 2002 or later that rescinds FASB Statement No. 4, Reporting Gains and Losses from Extinguishment of Debt, FASB Statement No. 64, Extinguishments of Debt Made to Satisfy Sinking-Fund Requirements, and FASB Statement No. 44, Accounting for Intangible Assets of Motor Carriers. This Statement amends FASB Statement No. 4 and FASB Statement No. 13, Accounting for Leases, to eliminate an inconsistency between the required accounting for sale-leaseback transactions. This Statement also amends other existing authoritative pronouncements to make various technical corrections, clarify meanings or describe their applicability under changed conditions. We are currently examining the effect of this pronouncement on the results of operations and financial position of Sipex, but currently we believe the effect will not be material.
On July 30, 2002, the FASB issued Statement No. 146, Accounting for Costs Associated with Exit or Disposal Activities. Statement No. 146 is based on the fundamental principle that a liability for a cost associated with an exit or disposal activity should be recorded when it (1) is incurred, that is, when it meets the definition of a liability in FASB Concepts Statement No. 6, Elements of Financial Statements", and (2) can be measured at fair value. The principal reason for issuing Statement 146 is the Boards belief that some liabilities for costs associated with exit or disposal activities that entities record under current accounting pronouncements, in particular Issue 94-3, do not meet the definition of a liability. Statement 146 nullifies Issue 94-3; thus, it will have a significant effect on practice because commitment to an exit or disposal plan no longer will be a sufficient basis for recording a liability for costs related to those activities. Statement No.146 is effective for exit and disposal activities initiated after December 31, 2002. Early application is encouraged; however, previously issued financial statements may not be restated. An entity would continue to apply the provisions of Issue 94-3 to an exit activity that it initiated under an exit plan that met the criteria of Issue 94-3 before the entity initially applied Statement 146. We are currently examining the effect of this pronouncement on the results of operations and financial position of Sipex, but currently we believe the effect will not be material.
3. Goodwill Impairment
For the quarter ended March 30, 2002, the Company adopted SFAS 142 effective and was no longer amortizing goodwill upon adoption, thereby eliminating annual goodwill amortization of approximately $376,000. Upon adoption of SFAS 142 on January 1, 2002, the Company performed a goodwill impairment test and concluded that there was no indication of impairment and recorded no impairment at January 1, 2002.
6
In the second quarter of 2002, the Company experienced significant changed circumstances resulting from the Companys stock price decreasing during the quarter, which reduced the Companys fair value. These circumstances indicated that the Companys goodwill might not be recoverable. As a result, the Company performed a goodwill impairment test in accordance with SFAS 142. The results of the impairment test indicated that the full amount of the Companys goodwill of $3.0 million was not recoverable and was written off. The impairment charge in the second quarter of 2002 compared with the quarterly goodwill amortization of $94,000 during 2001 under SFAS 121.
The proforma effects of the adoption of SFAS 142 on net income and earnings per share for the Company for the three and six months ended June 30, 2001 is as follows (in thousands):
Three Months Ended | Six Months Ended | |||||||
June 29, 2002 | June 29, 2002 | |||||||
Net (loss) as reported | $ | (6,305 | ) | $ | (11,333 | ) | ||
Add back: Goodwill amortization expense | 94 | 188 | ||||||
Adjusted net (loss) | $ | (6,211 | ) | $ | (11,145 | ) | ||
Basic and diluted (loss) per share, as reported | $ | (0.26 | ) | $ | (0.49 | ) | ||
Add back: Goodwill amortization expense | | 0.01 | ||||||
Proforma basic loss per share | $ | (0.26 | ) | $ | (0.48 | ) | ||
4. Long-term Debt
On April 16, 2002, the outstanding bank line of credit balance of $6.9 million was paid down to zero using proceeds from the private placement of Company common stock (see Note 8). The line of credit has a borrowing limit of $10.0 million with a borrowing base of 80% of the Companys accounts receivable. Funds advanced under the line bear interest at the banks base rate minus 0.5%, are due June 1, 2003 and are collateralized by substantially all our assets. For the quarter ended June 29, 2002, the Company was not in compliance with the net income, quick ratio and current ratio covenants on its bank line of credit and has obtained a waiver from the lender as of June 29, 2002, as well as an amendment to the net income requirements for the third and fourth quarter of 2002 and the quick ratio and current ratio requirements through June 1, 2003.
5. Net Income (Loss) Per Share
Net income (loss) per share-basic is based upon the weighted average number of common shares outstanding. Net income (loss) per share assuming dilution is based upon the weighted average number of common and common equivalent shares outstanding assuming dilution. Common equivalent shares, consisting of outstanding stock options, are included in the per share calculations where the effect of their inclusion would be dilutive.
A reconciliation of basic weighted average common shares with weighted average shares assuming dilution is as follows (in thousands):
Three Months Ended | Six Months Ended | |||||||||||||||
June 29, | June 30, | June 29, | June 30, | |||||||||||||
2002 | 2001 | 2002 | 2001 | |||||||||||||
Weighted average shares basic |
27,930 | 23,983 | 26,402 | 23,248 | ||||||||||||
Net effect of dilutive potential common shares outstanding
based on the Treasury stock method using the average
market price |
| | | | ||||||||||||
Weighted average common shares assuming dilution |
27,930 | 23,983 | 26,402 | 23,248 | ||||||||||||
Antidilutive potential common shares excluded from the
computation above |
5,116 | 4,102 | 5,204 | 3,971 | ||||||||||||
7
6. Valuation and Qualifying Accounts
The Company had the following activity for six months ended June 29, 2002 in the inventory and accounts receivable allowances:
Bad Debt & | ||||||||
Inventory | Returns | |||||||
Balance December 31, 2001 |
$ | 3,541 | $ | 2,444 | ||||
Charged to costs and expenses |
500 | 307 | ||||||
Deductions |
(1,199 | ) | (1539 | ) | ||||
Balance March 30, 2002 |
2,842 | 1,212 | ||||||
Charged to costs and expenses |
540 | 406 | ||||||
Deductions |
(1 | ) | (636 | ) | ||||
Balance June 29, 2002 |
$ | 3,381 | $ | 982 | ||||
7. Income Taxes
In the second quarter of 2002, the Company established a full valuation allowance and incurred a tax charge of $33.8 million for its deferred tax assets, which included significant net operating loss and tax credit carryforwards. The valuation allowance was established as the Company no longer believes that it is more likely than not that the net operating loss and tax credit carryforwards will be realized in the carryforward period. This change in estimate during the second quarter of 2002 was based on updated evaluations considering historical taxable income levels and expectations of future taxable income. For the first six months of 2001, the Company recorded an income tax benefit at a 39% effective rate. The Company recorded the tax benefit for the 2001 period and the related increase in deferred tax assets, as it believed it was more likely than not, considering the level of historical taxable income and expectations for future taxable income, that the operating loss would be utilized in the future to offset taxable income.
8. Stockholders Equity
On April 16, 2002, the Company issued 3.0 million shares of common stock through a private placement of securities, resulting in proceeds to the Company of approximately $23.4 million, net of placement agent fees and other costs related to the issuance. Proceeds from the offering of $6.9 million were used to pay down the Companys bank line of credit to zero and the balance of $16.5 million was used to provide funding for general corporate purposes.
8
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
From time to time, information provided by us, statements made by our employees or information included in its filings with the Securities and Exchange Commission (including in this Form 10-Q) may contain statements which are not historical facts. Such statements are referred to as forward-looking statements, and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. In particular, certain statements contained in the Managements Discussion and Analysis of Financial Condition and Results of Operations and Factors Affecting Future Results sections below that are not historical facts (including, but not limited to, statements concerning anticipated availability of capital for working capital and for capital expenditures, and statements regarding revenue recognition policies, including estimates of future returns) constitute forward-looking statements. Such statements are not promises or guarantees and are subject to risks and uncertainties that may cause our actual future results to differ materially from those stated in any forward-looking statements. Factors that may cause such differences include, but are not limited to, the factors discussed below and the other risks discussed in our other filings with the Securities and Exchange Commission. The following discussion should be read in conjunction with the financial statements and notes to the financial statements included in this Form 10-Q, as well as the Management Discussion and Analysis of Financial Condition and Results of Operations contained in our most recent 10-K. We caution you not to place undue reliance on the forward-looking statements contained in this Form 10-Q, which speak only as of the date hereof. Sipex disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.
Overview
We are a semiconductor company that designs, manufactures and markets, high performance, value-added analog integrated circuits, primarily for original equipment manufacturers doing business in the high growth markets of networking, computing and communications. Our four product families: power management, serial interface, analog display and optical storage constitute a broad, synergistic portfolio of standard analog ICs that address specific applications in desktop and portable computers, optical storage, handheld digital peripherals such as PDAs, cell phones and digital still cameras, and network and telecommunications infrastructure.
Results of Operations
The table below presents the statements of operations for the three and six month periods ended June 29, 2002 and June 30, 2001, as a percentage of net sales and provides the percentage increase of such items comparing the interim periods ended June 29, 2002 to the corresponding period from the prior fiscal year.
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
Percentage | Percentage | |||||||||||||||||||||||||
June 29, | June 30, | Increase | June 29, | June 30, | Increase | |||||||||||||||||||||
2002 | 2001 | (Decrease) | 2002 | 2001 | (Decrease) | |||||||||||||||||||||
Net sales |
100.0 | % | 100.0 | % | (12.3 | )% | 100.0 | % | 100.0 | % | (15.4 | )% | ||||||||||||||
Cost of sales |
111.4 | 111.9 | (12.6 | ) | 99.3 | 103.6 | (18.9 | ) | ||||||||||||||||||
Gross profit |
(11.4 | ) | (11.9 | ) | (15.5 | ) | 0.7 | (3.6 | ) | (116.5 | ) | |||||||||||||||
Operating expenses |
||||||||||||||||||||||||||
Research and development |
21.0 | 18.1 | 1.3 | 19.0 | 19.3 | (17.0 | ) | |||||||||||||||||||
Marketing and selling |
13.0 | 13.6 | (16.1 | ) | 13.5 | 13.5 | (15.4 | ) | ||||||||||||||||||
General and administrative |
15.6 | 9.9 | 38.2 | 13.0 | 10.2 | 7.7 | ||||||||||||||||||||
Amortization/impairment of goodwill |
17.6 | 0.5 | 3,074.5 | 9.0 | 0.5 | 1,487.2 | ||||||||||||||||||||
Restructuring and facility exit costs |
| 2.6 | (100.0 | ) | | 0.5 | (100.0 | ) | ||||||||||||||||||
Total operating expenses |
67.1 | 44.6 | 22.3 | 54.5 | 44.0 | 4.8 | ||||||||||||||||||||
(Loss) from operations |
(78.5 | ) | (56.5 | ) | (56.5 | ) | (53.8 | ) | (47.6 | ) | (4.3 | ) | ||||||||||||||
Other income (expense), net |
(1.9 | ) | (0.6 | ) | 193.8 | (2.2 | ) | 0.1 | (2,657.1 | ) | ||||||||||||||||
(Loss) before income taxes |
(80.5 | ) | (57.1 | ) | (23.6 | ) | (56.0 | ) | (47.5 | ) | (0.3 | ) | ||||||||||||||
Income tax expense (benefit) |
199.1 | (24.5 | ) | (812.1 | ) | 96.6 | (18.5 | ) | (540.8 | ) | ||||||||||||||||
Net (loss) |
(279.6 | )% | (32.5 | )% | (653.3 | )% | (152.6 | )% | (29.0 | )% | (345.2 | )% | ||||||||||||||
9
Net Sales
Net sales for the second quarter of 2002 decreased 12.3% to $17.0 million, as compared to $19.4 million for the same period last year. Net sales for the first six months of 2002 decreased 15.4% to $33.1 million, as compared to the same period last year. The decreases in net sales in the 2002 periods, as compared to the same periods last year, were due to the continued global slowdown in the semiconductor industry. Net sales from our interface and display driver product lines have decreased, in part, by an increase in net sales from our power management product lines. Shifts in product mix, lower average selling prices and our decision to exit certain product lines further contributed to the decreases in sales. International shipments increased 15.8% and domestic shipments decreased 51.4% in the second quarter, as compared to the corresponding 2001 period. For the first six-months of 2002, international shipments increased 5.4% and domestic shipments decreased 45.8%, as compared to the same 2001 period. International sales represented 77% and 58% of net sales for the second quarter of 2002 and 2001, respectively. For the first six months of 2002 and 2001, international sales represented 74% and 59% of net sales, respectively. The increase in the percentage of international sales in 2002 over 2001 was mainly due to a $4.2 million (51%) and $7.3 million (46%) decrease in domestic sales for the second quarter and first six months of 2002, respectively. Geographically, Sipex experienced sales growth of 77% in the Pacific Rim, while sales declined 39% in Japan, 18% in Europe and 51% in the United States in the second quarter of 2002, as compared to the second quarter of 2001.
Gross Profit
Gross (loss) decreased 15.5% to $1.9 million in the second quarter of 2002, as compared to $2.3 million for the same period last year. For the first six months of 2002, gross profit increased 116.5% to $232,000 over the gross profit (loss) of $(1.4) million for the first six months of 2001. As a percentage of net sales, gross (loss) decreased to 11.4% from 13.5% for the first quarter of 2002. For the first six months of 2002, gross profit as a percentage of net sales was 0.7%, as compared to a gross (loss) of 3.6% for the same 2001 period. The improved percentages, as compared to the respective prior year periods, were mainly due to improved yields and reduced spending. This overall improvement was partially offset by reduced net sales and continued lower capacity utilization within our manufacturing fab.
Research and Development
Research and development expenses for the second quarter of 2002 increased by $46,000 and decreased $1.3 million for the first six months of 2002 from the prior year levels. The decrease in research and development for the first six months of 2002 was due mainly to reduced process development expenses in the wafer fabrication facility in the first quarter of 2002, as compared to the same 2001 quarter, combined with cost controls put in place in the fourth quarter of 2001, which benefited the first quarter of 2002. Research and development expenses for the second quarter of 2002 reflected increased product development costs offset by continued cost controls. As a percentage of net sales, research and development increased to 21.0% for the second quarter of 2002, as compared to 18.1% in the same quarter of 2001. For the first six months of 2002, research and development expenses decreased to 19.0% from 19.3% for the same period last year.
Marketing and Selling
Marketing and selling expenses decreased $422,000 and $815,000 for the second quarter and first six months of 2002, respectively, as compared to the same 2001 periods. The decreases in marketing and selling expenses for the 2002 periods were due mainly to cost saving measures implemented in 2001 and decreased sales representative commissions on the lower sales. As a percentage of net sales, marketing and selling reduced to 13.0% for the second quarter of 2002, as compared to 13.6% for the same period last year and was 13.5% of net sales for the first six months of both years.
General and Administrative
General and administrative expenses for the second quarter of 2002 increased $731,000 or 38%, as compared to the same period in the previous year. For the first six months of 2002, general and administrative expenses increased $307,000 or 8% over the same period last year. The increased general and administrative expenses for the 2002 periods resulted from severance costs paid in the second quarter of 2002 to the Companys former Chief Executive Officer. Excluding severance costs, general and administrative expenses were lower as a result of cost saving measures. As a percentage of net sales, general and administrative expenses increased to 15.6% and 13.0%
10
for the second quarter and first six months of 2002, respectively, from 9.9% and 10.2% during the same periods last year.
Amortization/Impairment of Goodwill
For the quarter ended March 30, 2002, the Company adopted SFAS 142 effective and was no longer amortizing goodwill upon adoption, thereby eliminating annual goodwill amortization of approximately $376,000. Upon adoption of SFAS 142 on January 1, 2002, the Company performed a goodwill impairment test and concluded that there was no indication of impairment and recorded no impairment at January 1, 2002.
In the second quarter of 2002, the Company experienced significant changed circumstances resulting from the Companys stock price decreasing during the quarter, which reduced the Companys fair value. These circumstances indicated that the Companys goodwill might not be recoverable. As a result, the Company performed a goodwill impairment test in accordance with SFAS 142. The results of the impairment test indicated that the full amount of the Companys goodwill of $3.0 million was not recoverable and was written off. The impairment charge in the second quarter of 2002 compared with the quarterly goodwill amortization of $94,000 during 2001 under SFAS 121.
Other Income (Expense), Net
Other income (expense), net was $(329,000) and $(716,000) for the second quarter and first six months of 2002, respectively, as compared with $(112,000) and $28,000 for the same periods last year. The changes in the 2002 periods were mainly the result of decreased interest income in 2002 due to the use of $36.8 million of restricted cash in June 2001, which provided funds for the purchase of the land, building and equipment of the Milpitas wafer fabrication facility, formerly under an operating lease. The effect of the lower interest income was partially offset by reduced interest expense on lower average borrowings in the respective 2002 periods.
Income Tax Expense (Benefit)
In the second quarter of 2002, the Company established a full valuation allowance for its deferred tax assets, which included significant net operating loss and tax credit carryforwards. The valuation allowance was established, as the Company no longer believes that it is more likely than not that the net operating loss and tax credit carryforwards will be realized during the carryforward period. This change in estimate during the second quarter of 2002 was based on updated evaluations considering historical taxable income levels and expectations of future taxable income. For the first six months of 2001, the Company recorded an income tax benefit at a 39% effective rate. The Company recorded the tax benefit for the 2001 period and the related increase in deferred tax assets, as it believed it was more likely than not, considering the level of historical taxable income and expectations for future taxable income, that the operating loss would be utilized in the future to offset taxable income.
Liquidity and Capital Resources
As of June 29, 2002, we had working capital of $35.6 million and available funds of $11.4 million consisting of cash and cash equivalents and short-term investments as compared to working capital of $36.2 million and cash and cash equivalents of $4.9 million as of December 31, 2001. Cash used in operations was $7.4 million for the first six months of 2002 as compared to cash used in operations of $15.2 million for the first six months of 2001. The decrease in cash used in operations in the first six months of 2002 was mainly due to an increase in accounts payable and accrued expenses of $5.6 million versus a decrease of $3.0 million in 2001. The significantly greater net loss in 2002 was largely due to the $31.9 million tax charge as a result of the establishment of a valuation allowance for the full amount of our net deferred income taxes, as compared to a tax benefit of $7.2 million for the same period last year. This increased net loss, which also included a $3.0 million charge for goodwill, did not result in greater net cash used in our operations as the deferred tax charge and goodwill were not cash items.
Net cash used in investing activities was $8.8 million and $1.5 million for the first six months of 2002 and 2001, respectively. Additions to property plant and equipment were $2.9 million in 2002, as compared to $38.2 million in 2001. The expenditures in the 2001 period consisted mainly of the purchase of the land, building and equipment of our Milpitas manufacturing facility in June 2001 for $35.0 million, which was previously leased. Proceeds for the buyout in 2001 were provided by the liquidation of $36.8 million of restricted cash. Additionally in 2002, $6.0 million was used for the purchase of short term investments.
11
Net cash of $16.8 million and $22.2 million was provided by financing activities for the first six months of 2002 and 2001, respectively. In the second quarters of 2002 and 2001, we received cash of $23.4 million and $21.6 million, respectively, net of placement agent fees and other costs, through the private placements of 3.0 million and 2.2 million shares, respectively, of Sipex common stock. Proceeds from the 2002 offering were used to pay down our line of credit to zero, with the balance to be used for general corporate purposes. Proceeds from the 2001 offering were used to pay down our line of credit to $7.2 million from $11.0 million at the end of the first quarter of 2001, with the balance to be used to provide funding for operations.
For the quarter ended June 29, 2002, the Company was not in compliance with the net income, quick ratio and current ratio covenants on its bank line of credit and has obtained a waiver from the lender and an amendment to its net income requirements for the third and fourth quarters of 2002 and the quick ratio and current ratio covenants. The line of credit has a borrowing limit of $10.0 million with a borrowing base of 80% of the Companys accounts receivable. Funds advanced under the line bear interest at the banks base rate minus 0.5%, are due June 1, 2003 and are collateralized by substantially all our assets. There were no loans outstanding under the line of credit at June 29, 2002.
During 2002, due to the effects on our Company of the continued global slowdown in the semiconductor industry, we have consumed cash through operations of $7.4 million. Our focus over the next two quarters is to align our cost structure with our expected revenues to achieve a neutral cash flow from operations.
While Sipex expects to report a loss, at least through the third and fourth quarters of 2002, we believe that our currently available cash and investments combined with our cost reduction programs in process and our available borrowings will be sufficient to meet our cash and working capital requirements through at least the next twelve months. We may need to raise additional funds if our estimates change or prove inaccurate, if our cost reduction initiatives are insufficient, or in order for us to take advantage of unanticipated opportunities or to strengthen our financial position. Our ability to raise funds may be adversely affected by a number of factors relating to Sipex, as well as factors beyond our control, including the continued downturn in the semiconductor industry, volatility and uncertainty in the capital markets as well as increased market uncertainty following the terrorist attacks of September 11, 2001 and the ongoing U.S. war on terrorism. There can be no assurance that any financing will be available on terms acceptable to us, if at all, and any need to raise additional capital through the issuance of equity or debt securities may result in additional, and perhaps, significant dilution.
Critical Accounting Policies
The discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, sales returns, inventories, income taxes, restructuring and contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. There can be no assurance that actual results will not differ from those estimates.
We have identified the accounting policies below as the policies most critical to our business operations and the understanding of our results of operations. The impact and any associated risks related to these policies on our business operations is discussed throughout Managements Discussion and Analysis of Financial Condition and Results of Operations where such policies affect our reported and expected financial results. Our critical accounting policies relate to revenue recognition, sales returns, inventory reserves and income taxes and are explained below:
Revenue Recognition. Beginning in the fourth quarter of 2000, we began deferring revenue on ordinary course shipments to our largest distributor until the product is resold by the distributor to the end user (sell-through) because the arrangement with this distributor includes price concession and return rights, the potential impact of which we believed we could no longer reasonably estimate. For all other product sales, revenue is recognized at the time of shipment because these distributors/customers have no price protection and have limited return rights. In addition, management believes that it is able to estimate and establish appropriate reserves for future returns from these distributors. For product sales recognized at the time of shipment, Sipex accrues for estimated sales returns upon shipment based upon our estimates of future returns. In the fourth quarter of 2001, Sipex accepted distributor orders for certain products on a discounted basis for which the distributor has no rights of return other than for
12
product related issues, price protection or cancellation rights and which are not governed by the terms of the existing distributor contract. Revenue from these orders was recognized at the time of shipment, since these orders are non-cancelable, non returnable and for which such sales are not subject to the terms of the Companys distribution agreement with the distributor, including without limitation the price protection, restocking and other returns rights the distributor is entitled to in the agreement. Revenue from engineering service contracts is recorded as performance is completed.
Sales returns. We consider the estimate for reserve for sales returns to be a critical accounting policy. To estimate reserves for future sales returns, we regularly review our history of actual returns for each major product line. We also communicate monthly with our channel partners to gather information about sell-through activity, end user satisfaction and to determine the volume of inventory in the channel. We use the results of this analysis to estimate the reserves for sales returns. We adjust our reserves for future returns as is necessary, based on returns experience returns expectations and our communications with our channel partners.
In estimating reserves, we also consider unusual events and market conditions. It is possible that future events such as the introduction of a competitive product, product obsolescence, price competition, continued slowness in the semiconductor industry and distributors desire to decrease levels of inventory in the distribution channel could result in significant changes in customer demand and cause future returns to increase beyond historical levels. Management believes that it is able to estimate returns, and establish appropriate reserves for returns from customers for which Sipex recognizes revenue as of shipment, using the process described above. However, since reserves for estimated sales returns are recorded as a reduction in revenues, any significant difference between our estimated and actual returns experience, or changes in our estimate of reserves for future returns, would be reflected in our reported revenues in the period we determine that difference, and could have a material impact on our future results of operations.
Inventory reserves. We write down our inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. In the second quarter of 2001, we announced that a continued softness in our business led to a reduction in the demand on our inventory. During the several quarters preceding the announcement, we had expanded our internal fabrication facility and test operations in response to forecasts of significant revenue growth in our business. However, we experienced significant customer deferrals of delivery dates and order cancellations. Due to these customer actions, we were left in a position of higher than normal levels of inventory, which based on current and forecasted demand, would not be consumed during the products life cycle. As a result, we took an inventory charge of $2.6 million due to the sudden and significant decrease in forecasted revenue in our business.
Income taxes. We assess the realizability of our deferred tax assets by considering whether it is more likely than not that some or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the associated temporary differences become deductible. We considered the scheduled reversals of deferred tax liabilities and projected future taxable income in making this assessment. At December 31, 2001, we had U.S. net operating loss carryforwards of approximately $85.6 million, which were available to offset future Federal taxable income. These losses expire beginning in 2005 through 2021. We also had Massachusetts and California net operating loss carryforwards of approximately $63.0 million and $11.3 million, respectively, which are scheduled to expire beginning in 2005 to 2006. In addition, we had Federal and State tax credits of approximately $1.3 million and $1.2 million, which are scheduled to expire from 2002 to 2021, respectively.
In order to fully realize our deferred tax assets incurred to December 31, 2001, the Company will need to generate the following amounts of aggregate future taxable income within the periods noted below to prevent any of our loss or credit carryforwards from expiring unused.
13
Approximate | ||||||||||||
Cumulative | ||||||||||||
Type of Deductible | Years | Expiration | Taxable Income | |||||||||
Temporary Difference | Generated | Dates | Required | |||||||||
U.S. loss carryforwards |
1990 - 1995 | 2005 - 2010 | $22.7 million | |||||||||
U.S. loss carryforwards |
2000 - 2001 | 2020 - 2021 | $62.5 million | |||||||||
Massachusetts loss carryforwards |
2000 - 2001 | 2005 - 2006 | $62.5 million | |||||||||
California loss carryforwards |
2000 - 2001 | 2005 - 2006 | $32.4 million | |||||||||
U.S. tax credit carryforwards |
1995 - 2001 | 2010 - 2021 | $107.6 million | |||||||||
California tax credit carryforwards |
1998 - 2001 | 2006 - 2009 | $101.3 million |
Based on projections of taxable income over the next several years, and considering the limitation imposed by IRC Section 382, in the second quarter of 2002, due to what we believe may be a longer than previously estimated downturn in our industry, we no longer believe that it is more likely than not that none of our loss and credit carryforwards will expire unused and that we will realize the benefits of these deductible differences. We therefore established a valuation allowance in the second quarter and incurred a tax charge for the full amount of deferred income tax asset of $33.8 million.
Factors Affecting Future Results
Except for historical information contained herein, the matters set forth on this report on Form 10-Q, including the statements in the following paragraphs, are forward looking statements that are dependent on certain risks and uncertainties, without limitation, including such factors as, among others, delays in new product and process technology announcements and product introductions by us or our competitors, competitive pricing pressures, fluctuations in manufacturing yields, changes in the mix or markets in which our products are sold, availability and costs of raw materials, reliance on subcontractors, the cyclical nature of the semiconductor industry, industry-wide wafer processing capacity, political and economic conditions in various geographic areas, and costs associated with other events, such as under-utilization or expansion of production capacity, intellectual property disputes, litigation, or environmental regulation and other factors described below.
This Form 10-Q also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks described below and elsewhere in this Form 10-Q. You should carefully consider these risks before making an investment decision. These risks and uncertainties are not the only ones facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations. If any of these risks actually occur, our business, financial condition or results of operations could be materially adversely affected. In such case, the trading price of our common stock could decline and you could lose all or part of your investment.
OUR QUARTERLY AND ANNUAL OPERATING RESULTS ARE VOLATILE AND DIFFICULT TO PREDICT AND MAY CAUSE OUR STOCK PRICE TO FLUCTUATE.
Our quarterly and annual operating results are affected by a wide variety of factors that could materially and adversely affect net sales and profitability from period-to-period, including:
| overall economic conditions in the United States and abroad; | ||
| the cyclical nature of the semiconductor industry. | ||
| competitive pressures on selling prices; | ||
| the timing and cancellation of customer orders; | ||
| the availability of foundry capacity and raw materials; | ||
| fluctuations in yields; | ||
| changes in product mix; | ||
| our ability to introduce new products and technologies on a timely basis; | ||
| the introduction of products and technologies by our competitors; | ||
| market acceptance of our and our customers products; | ||
| the level of orders received that can be shipped in a quarter; | ||
| delays in shipments from our fabrication plant to assembly houses; |
14
| our ability to manufacture in the correct mix to respond to orders on hand and new orders received in the future; | ||
| the timing of investments in research and development, including tooling expenses associated with product development, process improvements and production; | ||
| the level of future product returns; and |
Due to the absence of substantial non-cancelable backlog, we typically plan our production and inventory levels based on internal forecasts of customer demand, which are highly unpredictable and can fluctuate substantially.
Our expense levels are based, in part, on expectations of future revenues and are, to a large extent, fixed in the short term. Our future revenues are difficult to predict and at times in the past we have failed to achieve revenue expectations. We may be unable to adjust spending in a timely manner to compensate for any unexpected revenue shortfall. If revenue levels are below expectations for any reason, operating results are likely to be harmed. Based on forecasts, we may increase our operating expenses for personnel and new product development and for inventory in anticipation of increasing sales levels; therefore, operating results would be harmed if increased sales are not achieved. In addition, we are limited in our ability to reduce costs quickly in response to any revenue shortfalls.
The semiconductor industry has, since 2001, been experiencing a prolonged and severe downturn that continues to adversely affect our results of operations. Our net revenue for the quarter and six month period ended June 29, 2002, decreased 12% and 15% from the same prior year periods. Our business depends on market demand for products using analog semiconductors. Prolonged downturns in the semiconductor industry lead to downturns in our net income and may cause continued losses and cash flow shortages.
As a result of the foregoing or other factors, we may experience material fluctuations in future operating results on a quarterly or annual basis, which could substantially harm our business, financial condition and operating results.
IT WOULD BE DIFFICULT FOR US TO ADJUST OUR SPENDING IF WE EXPERIENCE ANY REVENUE SHORTFALLS.
Our future revenues are difficult to predict and at times in the past we have failed to achieve our revenue expectations. Our expense levels are based in part, on our expectations of future revenues, and expense levels are, to a large extent, fixed in the short term. We may be unable to adjust spending in a timely manner to compensate for any unexpected revenue shortfall. If revenue levels are below expectations for any reason our operating results are likely to be harmed. Due to the absence of substantial non-cancelable backlog, we typically plan our production and inventory levels based on internal forecasts of customer demand, which are highly unpredictable and often fluctuate substantially. Because we are continuing to increase our operating expenses for personnel, new product development, and for inventory in anticipation of increasing sales levels, our operating results would be harmed if increased sales are not achieved. In addition, we are limited in our ability to reduce costs quickly in response to any revenue shortfalls.
WE HAVE SIGNIFICANT CAPITAL REQUIREMENTS TO MAINTAIN AND GROW OUR BUSINESS.
In order to remain competitive, we must continue to make significant investments in our facilities and capital equipment. We have obtained additional funding through the private placement of 3.0 million shares of Sipex common stock on April 16, 2002, which provided $23.4 million to the Company, net of placement agent fees and other costs of issuance. We may seek additional equity or debt financing from time to time and cannot be certain that additional financing will be available on favorable terms, if at all. Moreover, any future equity or convertible debt financing will decrease the percentage of equity ownership of existing stockholders and may result in substantial dilution, depending on the price at which the equity is sold or the debt is converted and the extent of our needs.
WE MAY EXPERIENCE DIFFICULTIES IN DEVELOPING AND INTRODUCING NEW OR ENHANCED PRODUCTS NECESSITATED BY TECHNOLOGICAL ADVANCES.
Our future success will depend, in part, upon our ability to anticipate changes in market demand and evolving technologies to remain competitive we must enhance our current products and to develop and introduce new products that keep pace with technological advancements and address the increasingly sophisticated needs of our customers. Our products may be rendered obsolete if we fail to anticipate or react to change, and, as a result, our
15
revenues and cash flow may be negatively impacted. Our success depends on our ability to develop new semiconductor devices for existing and new markets, to introduce these products in a timely manner and to have these products selected for design into new products of our customers. The development of these new devices is highly complex and from time to time we have experienced delays in completing the development of new products. Successful product development and introduction depends on a number of factors, including:
| accurate new product definition; | ||
| timely completion and introduction of new product designs; | ||
| availability of foundry capacity; | ||
| achievement of manufacturing yields; and | ||
| market acceptance of our products and our customers products. |
Our success also depends upon our ability to accurately specify and certify the conformance of our products to applicable standards and to develop our products in accordance with customer requirements. We cannot assure you that we will be able to adjust to changing market conditions as quickly and cost-effectively as necessary to compete successfully. We cannot assure you that we will be able to introduce new products in a timely and cost-effective manner or in sufficient quantities to meet customer demand or that these products will achieve market acceptance. Furthermore, we cannot assure you that our customers products will achieve market acceptance.
OUR MANUFACTURING PROCEDURES ARE VERY COMPLEX, WHICH MAY RESULT IN MANUFACTURING DIFFICULTIES.
Our manufacturing processes are highly complex and are continuously being modified in an effort to improve yields and product performance. Process changes can result in interruptions in production or significantly reduced yields that could result in product introduction or delivery delays. In addition, yields can be adversely affected by minute impurities in the environment or other problems that occur in the complex manufacturing process. Many of these problems are difficult to diagnose and are time-consuming or expensive to remedy. From time to time we have experienced yield variances. In particular, new process technologies or new products can be subject to especially wide variations in manufacturing yields and efficiency. We cannot assure you that our foundry or those of our suppliers will not experience yield variances or other manufacturing problems that result in delayed product introduction or delivery delays.
We currently rely on a variety of outside foundries to supply fully processed semiconductor wafers. There are significant risks associated with reliance on outside foundries, including the lack of assured wafer supply and control over delivery schedules, the unavailability of or delays in obtaining access to key process technologies and limited control over quality assurance, manufacturing yields, capacity and production costs. The occurrences of any supply or other problems such as the wafer shortages could have a negative impact on our business revenues and results of operations.
From time to time, the overall semiconductor industry has experienced significant growth, which has created industry-wide capacity shortages and extended lead times for contract assembly, raw wafers, capital equipment, foundry wafers and various other products and services that are critical to our performance. We are seeking to establish and maintain critical inventories and alternate sources to minimize the impact of our vendors capacity limitations. However, there may be future shortages of key services that harm our business and results of operations.
In an effort to reduce our reliance on outside fabricators for our wafers, we have built an in-house fabrication facility in Milpitas, California. We have brought wafer production in-house and have transitioned substantially all of our products to the new fab. The new facility is a sophisticated, highly complex, state-of-the-art factory. Actual production rates depend upon the continued reliable operation and effective integration of a variety of hardware and software components. We cannot be sure that all of these components will be fully functional or successfully integrated or that the facility will achieve the forecasted yield targets. We have experienced and may continue to experience unexpected delays and problems in qualifying and ramping up production at this new facility. For example, we experienced delays in production startup during the second quarter of 2002, which delayed shipments to our assembly houses, created a backup at our final test facility and resulted in lower than expected revenue from product distribution. Our failure to implement the new fab successfully and in a timely fashion may impact future revenue growth and operating results. In addition, the amount of capital expenditures required to bring the facility to full operating capacity could be greater than currently anticipated. Higher costs to bring the facility to full operating capacity will reduce margins and could harm our business and results of operations.
16
BRINGING OUR WAFER FABRICATION FACILITY TO FULL OPERATING CAPACITY COULD TAKE LONGER AND COST MORE THAN WE ANTICIPATED.
Our wafer fabrication facility in Milpitas, California began production in the second half of 1999. The facility is a sophisticated, highly complex, state-of-the-art factory. Actual production rates and manufacturing yields depend upon the reliable operation and effective integration of a variety of hardware and software components. We have experienced and may continue to experience unexpected delays and problems in qualifying and ramping up production in this facility. Our inability to achieve and maintain acceptable production capacity and yield levels will adversely impact our gross margins, profitability and financial condition. In addition, the amount of capital expenditures required to bring the facility to full operating capacity could be greater than we currently anticipate. Higher costs to bring the facility to full operating capacity will reduce our margins and could harm our business.
OUR WAFER FABRICATION FACILITY AND THE FACILITIES OF CERTAIN OF OUR SIGNIFICANT CUSTOMERS AND THIRD-PARTY WAFER SUPPLIERS ARE LOCATED IN AREAS SUSCEPTIBLE TO EARTHQUAKES.
Our in-house fabrication facility and the facilities of certain of our significant customers and third-party wafer suppliers are located in areas that are susceptible to earthquakes. Damage caused by earthquakes may result in shortages in water or electricity or transportation, which could limit the production capacity of our wafer facility and/or the ability of certain of our subcontractors to provide needed products. Any reduction in production capacity or the ability to obtain fully processed semiconductor wafers could cause delays or shortages in our product supply, which would harm our business. If our facilities or the facilities of our customers are damaged by future earthquakes, it could have a materially adverse effect on our business.
WE RELY ON OUTSIDE FOUNDRIES TO SUPPLY WAFERS AND THOSE FOUNDRIES MAY NOT PRODUCE AT ACCEPTABLE LEVELS.
We rely on outside foundries to supply fully processed semiconductor wafers. This reliance on outside foundries presents the following potential risks:
| lack of adequate wafer supply; | ||
| limited control over delivery schedules; | ||
| unavailability of or delays in obtaining access to key process technologies; and | ||
| limited control over quality assurance, manufacturing yields and production costs. |
Additionally, the manufacture of integrated circuits is a highly complex and technologically demanding process. Our third party foundries have, from time to time, experienced lower than anticipated manufacturing yields, particularly in connection with the introduction of new products and the installation and start-up of new process technologies. We cannot assure you that our outside foundries will not experience lower than expected manufacturing yields in the future.
Additionally, we purchase fully processed semiconductor wafers from outside foundries. We do not have a guaranteed level of production capacity at any of our foundries. The ability of each foundry to provide wafers to us is limited by the foundrys available capacity, and the foundrys allocation of its available capacity among multiple customers. We cannot assure you that our third party foundries will allocate sufficient capacity to satisfy our requirements. We have experienced decreased allocations of wafer supplies from our suppliers in the past, which reduced our capacity to ship products, and, thus, recognize revenues. Additionally, any sudden reduction or elimination of any primary source or sources of fully processed wafers could result in a material delay in the shipment of our products. If any other delays or shortages occur in the future, our revenues and business will be harmed.
WE MUST COMPLY WITH SIGNIFICANT ENVIRONMENTAL REGULATIONS, WHICH IS DIFFICULT AND EXPENSIVE.
We are subject to a variety of federal, state and local governmental regulations related to the use, storage, discharge and disposal of toxic, volatile or otherwise hazardous chemicals used in our manufacturing processes. Although we believe that our activities conform to presently applicable environmental regulations, the failure to
17
comply with present or future regulations could result in fines being imposed on us, suspension of production or a cessation of operations. Any failure by us to control the use of, or adequately restrict the discharge of, hazardous substances, or otherwise comply with environmental regulations, could subject us to significant future liabilities. In addition, we cannot assure you that we have not in the past violated laws or regulations, which violations could result in remediation or other significant liabilities, or that past use or disposal of environmentally sensitive materials in conformity with then existing environmental laws and regulations will not result in remediation or other significant liabilities under current or future environmental laws or regulations.
WE DEPEND ON DISTRIBUTORS WHO SELL DIRECTLY TO OEMs.
Approximately 60% of our net sales are from shipments of our product to distributors who sell directly to OEMs. Our agreements with distributors contain provisions for return of our product including stock rotations whereby distributors may return a percentage of their product based upon a percentage of their most recent six months shipments and in certain circumstances upon termination of the distributor relationship. We estimate the amount of future returns and have established reserves for estimated returns based upon information including sales during the period into the distribution channel, reported sell-through by distributors to OEMs, distributor inventory levels and the specific terms of the distributor agreements as well as historical returns experience. Beginning in the fourth quarter of 2000, we began deferring revenue on shipments to our largest distributor until the product is resold by the distributor to the end user (sell-through) because the arrangement with this distributor included price concessions and return rights the potential impact of which we believed we could no longer reasonably estimate.
WE MAY NOT SUCCESSFULLY EXPAND OUR SALES AND DISTRIBUTION CHANNELS.
An integral part of our strategy is to expand our sales and distribution channels. We are increasing resources dedicated to developing and expanding these channels but we may not be successful doing so. If we are successful in increasing our sales through indirect sales channels, we expect that those sales will be at lower per unit prices than sales through direct channels, and revenues we receive for each sale will be less than if we had sold the same product to the customer directly. Selling through indirect channels may also limit our contact with our customers. As a result, our ability to accurately forecast sales, evaluate customer satisfaction and recognize emerging customer requirements may be hindered. Even if we successfully expand our distribution channels, any new distributors may not have the technical expertise required to market and support our products successfully. If parties do not provide adequate levels of services and technical support, our customers could become dissatisfied, we could be required to devote additional resources for customer support, and our brand name and reputation could be harmed. Our strategy of marketing products directly to our customers and indirectly through distributors may result in distribution channel conflicts. Our direct sales efforts may compete with those of our indirect channels and, to the extent different distributors target the same customers, distributors may also come into conflict with each other. Although we have attempted to manage our distribution channels to avoid potential conflicts, channel conflicts may harm our relationships with existing sales representatives or distributors or impair our ability to attract sales representatives.
OUR FUTURE SUCCESS DEPENDS ON RETAINING OUR KEY PERSONNEL AND ATTRACTING AND RETAINING ADDITIONAL HIGHLY QUALIFIED EMPLOYEES.
Our success depends upon the continued service of our executive officers and other key management and technical personnel, and on our ability to continue to attract, retain and motivate qualified personnel, such as experienced analog circuit designers. The competition for these employees is intense. Most of our employees are employees at-will and we have no fixed-term employment agreements with most employees, which means that they can terminate their employment at any time. We cannot assure you that we will be able to retain our design engineers, executive officers and other key personnel. The loss of the services of one or more of our design engineers, executive officers or other key personnel or our inability to recruit replacements for these personnel or to otherwise attract, retain and motivate qualified personnel could seriously impede our success.
WE MAY FACE SIGNIFICANT RISKS IN EXPANDING OUR INTERNATIONAL OPERATIONS.
We derive a significant portion of our net sales from international sales, including Asia, which are subject to certain risks, including:
| unexpected changes in legal and regulatory requirements; | ||
| changes in tariffs; | ||
| exchange rates and other barriers; |
18
| political and economic instability; | ||
| difficulties in accounts receivable collection; | ||
| difficulties in managing distributors or representatives; | ||
| difficulties in staffing and managing international operations; | ||
| difficulties in protecting our intellectual property overseas; | ||
| the seasonality of sales; and | ||
| potentially adverse tax consequences. |
International sales in the second quarters of 2002 and 2001 were $13.1 million and $11.3 million, respectively, or 77% and 58% of total net sales, respectively. There can be no assurance that economic troubles in any geographic area of the world will not have a material adverse effect on our business, results of operations and financial condition.
WE HAVE ONLY LIMITED PROTECTION FOR OUR PROPRIETARY TECHNOLOGY.
The semiconductor industry is characterized by frequent litigation regarding patent and other intellectual property rights. Although we are not aware of any pending or threatened patent litigation that we consider material, there can be no assurance that third parties will not assert claims against us with respect to existing or future products or technologies and we have been subject to such claims in the past. In litigation to determine the validity of any third party claims, such litigation, whether or not determined in our favor, could result in significant expense to us and divert the efforts of our management personnel from productive tasks. In the event of an adverse ruling in such litigation, we may be required to discontinue the use of certain processes, cease the manufacture, use and sale of infringing products, expend significant resources to develop non-infringing technology or obtain licenses to the infringing technology. There can be no assurance that licenses will be available on acceptable terms, or at all, with respect to disputed third party technology. In the event of a successful claim against us and our failure to develop or license a substitute technology at a reasonable cost, our business, financial condition and results of operations would be materially and adversely affected.
We cannot assure you that foreign intellectual property laws will protect our intellectual property rights. Furthermore, we cannot assure you that others will not independently develop similar products, duplicate our products or design around any of our patents. We may be subject to, or may initiate, interference proceedings in the patent office, which can demand significant financial and management resources.
WE MAY BECOME SUBJECT TO INFRINGEMENT CLAIMS
Although we do not believe that our products infringe the proprietary rights of any third parties, we have in the past been subject to infringement claims and third parties might assert infringement claims against us or our customers in the future. Furthermore, we may initiate claims or litigation against third parties for infringement of our proprietary rights or to establish the validity of our proprietary rights. Litigation, either as a plaintiff or a defendant, would cause us to incur substantial costs and divert management resources from productive tasks. Any litigation, regardless of the outcome, could harm our business. If it appears necessary or desirable, we may seek licenses to intellectual property that we are allegedly infringing. We may not be able to obtain licenses on acceptable terms. The failure to obtain necessary licenses or other rights could harm our business.
IF WE ARE UNABLE TO COMPETE EFFECTIVELY WITH EXISTING OR NEW COMPETITORS, WE WILL EXPERIENCE FEWER CUSTOMER ORDERS, REDUCED REVENUES, REDUCED GROSS MARGINS AND LOST MARKET SHARE.
We compete in markets that are intensely competitive, and which are subject to both rapid technological change and continued price erosion. Our competitors include many large domestic and foreign companies that have substantially greater financial, technical and management resources than us. Loss of competitive position could result in price reductions, fewer customer orders, reduced revenues, reduced gross margins and loss of market share, any of which would affect our operating results and financial condition. To remain competitive, we continue to evaluate our manufacturing operations, looking for additional cost savings and technological improvements. If we are not able to successfully implement new process technologies and to achieve volume production of new products at acceptable yields, our operating results and financial condition may be affected. Our future competitive performance depends on a number of factors, including our ability to:
19
| accurately identify emerging technological trends and demand for product features and performance characteristics; | ||
| develop and maintain competitive products; | ||
| enhance our products by adding innovative features that differentiate our products from those of our competitors; | ||
| bring products to market on a timely basis at competitive prices; | ||
| respond effectively to new technological changes or new product announcements by others; | ||
| increase device performance and improve manufacturing yields; | ||
| adapt products and processes to technological changes; and | ||
| adopt and/or set emerging industry standards. |
We cannot assure you that our design, development and introduction schedules for new products or enhancements to our existing and future products will be met. In addition, we cannot assure you that these products or enhancements will achieve market acceptance, or that we will be able to sell these products at prices that are favorable to us
OUR STOCK PRICE HAS BEEN VOLATILE AND COULD CONTINUE TO REMAIN VOLATILE.
The trading price of our common stock is subject to wide fluctuations in response to quarter-to-quarter variations in operating results, announcements of technological innovations or new products by us or our competitors, general conditions in the semiconductor manufacturing and electronic markets, changes in earnings estimates by analysts, or other events or factors. In addition, the public stock markets have experienced extreme price and trading volume volatility in recent months. In the quarter ended December 31, 2000, our stock closing price ranged from a high of $45.125 to a low of $15.875. In the second quarter of 2002 ending June 29, 2002, our stock closing price ranged from a high of $11.20 to a low of $4.09. This volatility has significantly affected the market prices of securities of many technology companies for reasons frequently unrelated to the operating performance of the specific companies. These broad market fluctuations may adversely affect the market price of our common stock.
WE COULD FACE SECURITIES LITIGATION IF OUR STOCK PRICE REMAINS HIGHLY VOLATILE.
In the past, securities class action litigation has often followed periods of volatility in the market price of a companys securities. We were recently named in two virtually identical purported securities class action lawsuits. The complaints alleged, among other things, that our financial statements for the second and third quarters of fiscal year 2000, contained incorrect statements, and sought unspecified damages. On April 12, 2002, the U.S. District Court dismissed both suits with prejudice.
The litigation process is inherently uncertain and unpredictable, however, and there can be no guarantee that we will not become subject to such suits in the future. Moreover, there can be no guarantee that if we do become subject to such suits, that the ultimate outcome will be similar to the cases noted above. Any litigation could result in substantial costs and a diversion of managements attention and resources, which could harm our business.
Item 3. Quantitative and Qualitative Disclosures about Market Risk:
Sipex invests excess cash in financial instruments that are sensitive to market risks as part of its investment strategy. None of these market-sensitive instruments are held for trading purposes. Sipex does not own derivative financial instruments in its portfolio. The investment portfolio contains instruments that are subject to the risk of a decline in interest rates.
Investment Rate Risk The Companys financial instruments are primarily money market funds. The Company does not believe that it has a material exposure to interest rate risk.
20
Part II: OTHER INFORMATION
Item 1. Legal Proceedings
Between July 10 and July 19, 2001, two virtually identical purported securities class action lawsuits were filed in the United States District Court for the District of Massachusetts, captioned Darren Suprina v. SIPEX Corp. et al (C.A. No. 01-11185-DPW) and Doug Howell v. SIPEX Corp. et al (C.A. No. 01-11243-DPW). The suits named as defendants SIPEX and certain officers of SIPEX. The suits were purportedly brought on behalf of a class of all persons who purchased SIPEXs common stock from July 20, 2000 through and including January 11, 2001. The suits alleged, among other things, that SIPEXs financial statements for the second and third quarters of fiscal year 2000 contained misstatements and asserted violations of Section 10(b) of the Securities and Exchange Act of 1934 and SEC Rule 10b-5. The suits sought unspecified damages awards. On April 12, 2002, the United States District Court dismissed both suits with prejudice.
Item 2. Changes in Securities and Use of Proceeds:
On April 16, 2002, the Company issued and sold 3.0 million shares of SIPEX common stock in a private placement pursuant to Section 4(2) of the Securities Act of 1933 to certain institutional investors for an aggregate amount of $25.5 million. The Company paid approximately $2.1 million in placement agent fees and other costs related to the issuance, resulting in net proceeds to the Company of approximately $23.4 million. Proceeds from the offering were used to pay down the Companys bank line of credit to zero and the balance of $16.5 million is to provide funding for general corporate purposes.
Item 4. Submission of Matters to a Vote of Security Holders
The Annual Meeting of Shareholders was held on May 17, 2002. Holders of an aggregate of 24,909,584 shares at the close of business on April 8, 2002 were entitled to vote at the meeting. At such meeting, our shareholders voted to elect Mr. James E. Donegan to serve as director for a term of three years. There were 19,287,550 votes for the election of Mr. Donegan and 2,843,275 votes withheld for his election. There were no broker non-votes or abstentions.
The term of office for the following directors continued after the meeting: Douglas M. McBurnie, Manfred Loeb, Lionel H. Olmer, John l. Sprague and Willy M. C. Sansen.
Item 6. Exhibits and Reports on Form 8-K
a) Exhibits
10.1 Comerica Bank California Waiver
99.1 Certification of Chief Executive Officer
99.2 Certification of Chief Financial Officer
b) Reports on Form 8-K
On April 15, 2002, Sipex filed a Current Report on Form 8-K (SEC file No. 000-27892) to announce the sale of 3.0 million shares of common stock to institutional investors for an aggregate cash price of $25.5 million, resulting in net proceeds to the Company of $23.4 million, net of placement agent fees and other expenses. |
21
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SIPEX CORPORATION | ||||||||
DATE: August 12, 2002 | BY | /s/ Frank R. DiPietro | ||||||
Frank R. DiPietro | ||||||||
Executive Vice President, Finance | ||||||||
Chief Financial Officer & Treasurer | ||||||||
(Duly Authorized Officer & | ||||||||
Principal Financial Officer) |
22